Abbott sales 18% fall due to anticipation of COVID testing sales declines

Abbott sales 18% fall due to anticipation of COVID testing sales declines

Source: 
Medical Marketing and Media
snippet: 


Abbott Laboratories’ reported sales fell 18.1% in Q1 due to what the company called an “anticipated decline” in COVID-19 testing-related sales compared to 2022.